Wetenschappelijke publicaties van Bordet

Wetenschappelijke publicaties van Bordet

  • Unmet supportive care needs among head and neck cancer survivors beyond 5 years after diagnosis: a multinational cohort study.

  • Auteurs Jansen F, Eerenstein SE, Taylor KJ, Amdal CD, Bjordal K, Astrup GL, Herlofson BB, Duprez F, Gama RR, Jacinto AA, Hammerlid E, Scricciolo M, Fanetti G, Guntinas-Lichius O, Inhestern J, Dragan T, Fabian A, Boehm A, Wöhner U, Kiyota N, Krüger M, Bonomo P, Pinto M, Nuyts S, Silva JC, Stromberger C, Specenier P, Tramacere F, Bushnak A, Perotti P, Plath M, Paderno A, Stempler N, Kanellopoulou A, Singer S, Verdonck-de Leeuw IM
  • Revue Lancet Reg Health Eur
  • Date de publication 2025-12
Unmet supportive care needs among head and neck cancer survivors beyond 5 years after diagnosis: a multinational cohort study.

  • A modified Delphi consensus on periprosthetic infection in orthopaedic oncology : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM).

  • Auteurs Jeys L, Botello E, Boyle RA, Ebeid W, Houdek MT, Kurisunkal VJ, Morgan-Jones R, Morris GV, Puri A, Ruggieri P, Laitinen MK, Abad Repiso S, Abdelbary H, Abiad Mejia A, Abood AA, Abou-Nouar G, Abril Martin JC, Abu Elhamd A, Abudu A, Acosta M, Ae K, Agarwal M, Ajit Singh V, Akiyama T, Albergo JI, Alexander J, Alfaro PA, Alpan B, Alshaygy I, Amaya-Valero J, Anderson M, Andreou D, Annabell L, Anthony C, Aoude A, Arteagoitia-Colino I, Asavamongkolkul A, Aston W, Asua Mentxaka L, Azzopardi C, Baad-Hansen T, Badr IT, Baixauli-Garcia F, Baker G, Balach T, Baldi GG, Barry J, Basile G, Bastoni S, Basuki MH, Bauer H, Bayliss L, Becker RG, Bedi A, Benevenia J, Bengoa F, Bergh P, Bergovec M, Bernthal N, Binitie O, Boddie D, Boffano M, Bonilla Huertas P, Borgognoni AB, Botchu R, Bramer J, Branford-White H, Brar R, Broekhuis D, Broida SE, Budny T, Burke ZD, Cabrolier J, Calvo Tapies JR, Calvo-Haro JA, Campanacci D, Cardoso R, Carey Smith R, Carvallo PI, Casales Fresenga N, Casanova JM, Ceballos O, Cebrian Parra JL, Certain LK, Chacon Cartaya S, Chan CM, Cho YJ, Choong P, Chung YG, Ciechanowicz D, Clara-Altamirano MA, Clever D, Colina SM, Consuegra L, Couch C, Cribb G, Cuervo C, Cusick LA, Dadia S, Dagher T, Dammerer D, Davies M, Davies N, de la Rosa Martino LP, de Santos de la Fuente FJ, de Vaal M, Deckers C, Delgado Obando J, Deo S, Deventer N, Di Bella C, Domson G, Donati DM, Dorleijn DM, Du Toit J, Dunne D, Duran Ciarrochi R, Ekman E, El Ghoneimy AM, Endo M, Eralp L, Etaiwi M, Evans S, Evrard R, Eward W, Farese A, Ferguson PC, Ferreira Cardoso PF, Fiorenza F, Flint M, Flores H, Freitas J, Fuchs B, Fujiwara T, Funovics PT, Galli Serra M, Gamie Z, Garces-Zarzalejo C, Gazendam A, Gebert C, Gerbers JG, Gerrand C, Ghert M, Ghosh KM, Gibbons M, Gomez-Mascard A, Gomez-Mier LC, Gomez-Vallejo J, Gonzalez MR, Gonzalez-Lizan F, Gosheger G, Goudie S, Goulding K, Goumenos SD, Griffin A, Gulia A, Gupta S, Gupta A, Guzman M, Haitham M, Hardes J, Hardoy F, Hasan Y, Hauer G, Havard H, Haydon R, Healey J, Hernandez Gonzalez N, Hernandez-Lopez A, Hesla A, Hess M, Hilton T, Hongsaprabhas C, Hornicek F, Hosking K, Houghton E, Idowu OK, Ippolito J, Isler M, Iwata S, Jagiello J, Jenkins N, Jeys T, Jeys C, Johnson L, Johnston A, Joo MW, Jutte PC, Kaldas K, Kamat A, Kannan S, Kapanci B, Khan Z, Kobayashi H, Kollender Y, Koob S, Kotrych D, Kyte R, Lamo de Espinosa Vazquez de Sola JM, Lazarides AL, Le Nail LR, Legosz P, Lehner B, Leithner A, Lejoly M, Lewis VO, Lin P, Linares F, Lozano-Calderon S, Mahendra A, Mahyudin F, Mandia Mancebo FJ, Martos Torrejon S, Marx C, Mascard E, Mattei JC, McCullough L, McMahon S, Medellin Rincon MR, Miller B, Miwa S, Molina Uribe G, Moon B, Moriel Garcesco DJ, Morris C, Morrison S, Mottard S, Moura M, Muster L, Nakayama R, Narhari P, Navas A, Nayak P, Neugebauer J, Newman ET, Nieminen J, Nyqvist E, Nystrom L, O'Reilly-Harbidge S, O'Toole G, Oliveira V, Olivier A, Omar M, Ortiz-Cruz EJ, Ozger H, Ozkan K, Pala E, Palmerini E, Pang G, Papagelopoulos P, Paraliticci G, Parry MC, Patton S, Peake D, Peiro Ibanez A, Perez Munoz I, Perianayagam GR, Petersen MM, Ploegmakers J, Pollock R, Powell G, Pretell J, Puetzler J, Qamar F, Raja A, Rajasekaran RB, Ramkumar DB, Randall RL, Rankin KS, Raskin KA, Rassppan K, Repsa L, Ropars M, Rose P, Sadek W, Salcedo G, Saleemi A, Sambri A, Sar H, Scanferla R, Schubert T, Schwarze J, Scoccianti G, Scrimshire A, Sekita T, Shehadeh A, Shoaib A, Shreemal B, Shumelinsky F, Siegel G, Silveri C, Silverwood R, Sinnaeve F, Sison J, Slade A, Smolle MA, Snyman F, Sommerville S, Sood S, Spiguel A, St-Yves H, Staals EL, Stacchiotti S, Stavropoulos N, Steadman P, Stevenson JD, Sullivan M, Sys G, Szostakowski B, Tamburini A, Taniguchi Y, Temple T, Theil C, Thorkildsen J, Tibbo M, Tillman R, Toda Y, Tootsi K, Torner Rubies F, Traub F, Trikoupis I, Tsagkozis P, Tsoi K, Tsuchiya H, Vainio VM, Valcarcel A, Valencia J, Van Beeck A, Van de Sande M, Van Den Berghe T, Van der Geest I, Van der Heijden L, Van der Wal R, Van Langevelde K, Vaz G, Velez Villa R, Verspoor F, Verstraete K, Visgauss J, Vyrva O, Wafa H, Walter S, Wan Ismail WF, Wang E, Wang PQ, Warnock D, Werier J, Weschenfelder W, Wong KC, Woulthuyzen-Bakker M, Wunder J, Wysinghe I, Yamamoto N, Ye Z, Yoon SJ, Zainul Abidin S, Zamora T, Zecchetto P, Zhang L, Zumarraga JP
  • Revue Bone Joint J
  • Date de publication 2025-12
A modified Delphi consensus on periprosthetic infection in orthopaedic oncology : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM).

  • Imlunestrant, an oral selective estrogen receptor degrader, in combination with HER2 directed therapy, with or without abemaciclib, in ER-positive, HER2-positive advanced breast cancer: results from the phase 1a/1b EMBER study.

  • Auteurs Bhave M, Jhaveri KL, Kaufman PA, Aftimos P, Lombard J, Giridhar KV, Im SA, Ma CX, Lee KT, Kim SB, Sohn J, Li Y, Yuen E, Estrem ST, Nguyen B, Makena MR, Ismail-Khan R, Beeram M
  • Revue Breast Cancer Res
  • Date de publication 2025-12
Imlunestrant, an oral selective estrogen receptor degrader, in combination with HER2 directed therapy, with or without abemaciclib, in ER-positive, HER2-positive advanced breast cancer: results from the phase 1a/1b EMBER study.

  • Real-world outcomes in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia treated with ponatinib - final 6-year results from a Belgian registry.

  • Auteurs Devos T, Deeren D, Theunissen K, Selleslag D, Bailly B, Havelange V, Lewalle P, Meers S, Benghiat FS, Gadisseur A, Granacher N, Vanstraelen G, Vellemans H, Becker A, Janssen M, Vrelust I, Lejeune M, Van de Velde A, Triffet A, Beck M, Sebti H, Mazure D
  • Revue Hematology
  • Date de publication 2025-12
Real-world outcomes in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia treated with ponatinib - final 6-year results from a Belgian registry.

  • Core Outcome Set of the Surgical Treatment of Differentiated Thyroid Carcinoma: International Consensus by Delphi Study.

  • Auteurs van de Berg DJ, Vriens MR, van Santen HM, Seur A, Clement SC, van Trotsenburg ASP, Bruinstroop E, Kruijff S, Peeters RP, Verburg FA, Netea-Maier R, Jamaludin FS, Nieveen van Dijkum EJM, Derikx JPM, Engelsman AF
  • Revue Thyroid
  • Date de publication 2025-12
Core Outcome Set of the Surgical Treatment of Differentiated Thyroid Carcinoma: International Consensus by Delphi Study.
Erasme hospital

Erasmeziekenhuis

Bekijk alle wetenschappelijke publicaties van Erasme

Wetenschappelijke publicaties van Erasme
Huderf hospital

Queen Fabiola Kinderziekenhuis

Bekijk alle wetenschappelijke publicaties van het Koningin Fabiola Kinderziekenhuis

Wetenschappelijke publicaties van het Koningin Fabiola-Kinderziekenhuis
Decorative image of doctor and patient

Alle wetenschappelijke publicaties van het H.U.B.

Bekijk alle wetenschappelijke publicaties van het H.U.B.

Alle wetenschappelijke publicaties